Physician profile
Peter Karl Kemp
NPI 1174107460
$1,645.72
in general payments reported to CMS, 2019-2025
12 companies · $474 in 2025
The $474 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $1,172 · 2025: $474.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,277 · Travel and Lodging: $369.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,276.77 |
| Travel and Lodging | $368.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $368.95 | 2024 | |
| International Life Sciences | $261.00 | 2024 | Flexband |
| Baxter Healthcare | $231.47 | 2024 | Floseal |
| Integra Lifesciences Corporation | $194.41 | 2024-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Medshape, INC. | $144.76 | 2025 | |
| Arthrex, INC. | $133.22 | 2024 | Arthrex |
| Stryker Corporation | $123.42 | 2024-2025 | Ortholoc 2 Lapifuse, Variax, Easyfuse |
| Bioventus LLC | $66.85 | 2024-2025 | Exogen Ultrasound Bone Healing System |
| Smith+Nephew, INC. | $35.56 | 2024 | Grafix Pl |
| Djo, LLC | $32.31 | 2024 | Cmf |
| Impactortho, INC. | $31.21 | 2024-2025 | |
| Mimedx Group, INC. | $22.56 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Kemp listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.